The Trust has purchased the apartment on the 61st floor of Tower A, which is 17,384 sq ft big, according to documents ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

The Zydus Family Trust, associated with Zydus Lifesciences Limited (formerly Cadila Healthcare Limited), a leading Indian ...

Zydus Lifesciences, previously Cadila Healthcare Ltd, is a leading company in the international life sciences industry. With its headquarters situated in Ahmedabad, Gujarat, it formulates, ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million euros (nearly $280 million) as part of its plans to expand further in the ...

Zydus Lifesciences share price today, March 19: The share price of Zydus Lifesciences has risen by 1.8% in the past five trading sessions. (Image: Freepik) Zydus Lifesciences rose 3% to an intra ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences share price extended the gains on third consecutive session on March 19, rising more than 1 percent after company received final approval from USFDA for Apalutamide Tablets, 60 ...

The Board has extended Rajivnayan Rahulkumar Bajaj's tenure as Managing Director and Chief Executive Officer for another five years, starting April 1. Additionally, Abhinav Bindra has been ...